>
OTOY | GTC 2023: The Future of Rendering
Humor: Absolutely fking hilarious. - Language warning not for children
President Trump's pick for Surgeon General Dr. Janette Nesheiwat is a COVID freak.
What Big Pharma, Your Government & The Mainstream Media didn't want you to know.
Forget Houston. This Space Balloon Will Launch You to the Edge of the Cosmos From a Floating...
SpaceX and NASA show off how Starship will help astronauts land on the moon (images)
How aged cells in one organ can cause a cascade of organ failure
World's most advanced hypergravity facility is now open for business
New Low-Carbon Concrete Outperforms Today's Highway Material While Cutting Costs in Minnesota
Spinning fusion fuel for efficiency and Burn Tritium Ten Times More Efficiently
Rocket plane makes first civil supersonic flight since Concorde
Muscle-powered mechanism desalinates up to 8 liters of seawater per hour
Student-built rocket breaks space altitude record as it hits hypersonic speeds
Researchers discover revolutionary material that could shatter limits of traditional solar panels
(Natural News) Cannabinoids may show potential in the treatment of various skin diseases, according to a recent analysis. Health experts at the University of Colorado Anschutz Medical Campus examined current literature on the effects of cannabinoids on skin diseases and confirmed that pharmaceutical products containing the compound may prove effective in treating eczema, psoriasis, and both atopic and contact dermatitis.
According to senior author Dr. Robert Dellavalle, Associate Professor of Dermatology at the University of Colorado School of Medicine, the compound's most promising effect is addressing severe itch. The senior author cited one study where eight out of 21 patients who used a cannabinoid cream twice daily for three weeks were able to completely cure severe itching or pruritus. According to the study, cannabinoids helped relieve dry skin, which triggers itch in patients.
The research team also found that tetrahydrocannabinol, the active ingredient in marijuana, helped reduce swelling and inflammation in mice. The experts also noted that animal models of melanoma exhibited a significant inhibition of tumor growth following tetrahydrocannabinol injection. According to Dellavalle, the cannabinoid's anti-inflammatory properties may play a role in the beneficial effects of therapies using the compound. Dellavalle said the treatments used were cannabinoid drugs that spurred little to no psychotropic effects, indicating that they can be used in skin disorders. He also stressed that cannabinoids may be an effective alternative for patients who were non-responsive to other itch and skin disease therapies.